You are here: Home » PTI Stories » National » News
Business Standard

Sun Pharma recalls about 14k cartons of anaesthesia injection

Press Trust of India  |  Hyderabad 

has said its US subsidiary has started voluntarily recalling 13,918 cartons of Injection of 10 mg and 20 mg strengths from US market at hospital level, following the identification of "particulate matter identified as glass" in the product.

"Industries, (SPII), a wholly owned subsidiary of Industries, is voluntarily recalling three lots of for Injection, 10 mg (lyophilized powder), and one lot of for Injection, 20 mg (lyophilized powder) to the hospital level.

The Vecuronium Bromide for Injection has been found to contain particulate matter identified as glass," said in a letter to the on January 8.

Vecuronium Bromide for Injection is used as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle during or and is packaged in a glass vial.

This product was distributed nationwide to wholesale customers and medical facilities, the said.

The administration of a glass particulate, if present in an intravenous drug, may result in or swelling in response to the foreign material.

More serious potential outcomes would include blockage and clotting in blood vessels, which may be life-threatening.

To date, the company has not received any reports of adverse events related to this recall, the letter said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, January 09 2019. 15:45 IST